Please login to the form below

systemic lupus erythematosus

This page shows the latest systemic lupus erythematosus news and features for those working in and with pharma, biotech and healthcare.

BMS psoriasis drug hits the mark in phase II

BMS also has phase II studies of the drug ongoing in other indications including systemic lupus erythematosus and Crohn's disease.

Latest news

AstraZeneca’s Lupus treatment misses mark in trial

AstraZeneca’s anifrolumab has failed to meet the primary objective in a late-stage clinical trial in moderate-to-severe systemic lupus erythematosus (SLE). ... control. The result of this trial is disappointing for patients and the lupus community.”
Ablynx spurns Novo Nordisk and cuts €3.9bn deal with Sanofi

Ablynx also has vobarilizumab for systemic lupus erythematosus in phase II, with results due in the first half of the year that will trigger an option decision by AbbVie.
GSK closes in on EU approval for triple COPD therapy

Benlysta is used as an add-on treatment for adults with active, autoantibody-positive systemic lupus erythematosus (SLE).
Celgene pays $300m upfront for immunology start-up Delinia

The drug has potential in a variety of autoimmune diseases such as systemic lupus erythematosus and rheumatoid arthritis, says Celgene, which also claims rights to related second-generation candidates.
Merck's pharma unit faces tougher 2017 as fertility boost recedes

Meanwhile, Merck suffered a setback in its mid-stage pipeline recently after its systemic lupus erythematosus (SLE) candidate atacicept failed to meet its objectives in a clinical trial, although it did

More from news
Approximately 2 fully matching, plus 27 partially matching documents found.

Latest Intelligence

Pharma deals during September 2012

In a similar vein, Biogen Idec has sold its royalty rights to Benlysta (belimunab) for the treatment of systemic lupus erythematosus, to DRI Capital Managed Fund. ... Royalty monetisation. Benlysta (belimunab) for the treatment of systemic lupus

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Latest appointments

Santhera CEO Klaus Schollmeier joins SuppreMol

This product is SM101, which is being investigated for its use in the treatment of primary immune thrombocytopenia (ITP) and systemic lupus erythematosus (SLE).

More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.

Latest from PMHub

Random42 Scientific Communication

Creativity International Awards - Systemic Lupus Erythematosus . 2016 - Silver. Creativity International Awards - Normal Hemostasis and von Willebrand Factor (VWF). ... 2016 - Bronze. The Telly Awards - Systemic Lupus Erythematosus. 2016 - Bronze.
Random42 Scientific Communication

Creativity International Awards - Systemic Lupus Erythematosus . 2016 - Silver. Creativity International Awards - Normal Hemostasis and von Willebrand Factor (VWF). ... 2016 - Bronze. The Telly Awards - Systemic Lupus Erythematosus. 2016 - Bronze.

More from PMHub
Approximately 0 fully matching, plus 2 partially matching documents found.

Featured jobs

Client Services Director – Medical Education Agency – North West...: Salary TBC

Project / Account Manager (Medical Education): Salary TBC

Associate Director, Market Access & HEOR – North-West: Negotiable

Events Manager – Med Comms – Surrey: Salary TBC

Programme Director, Healthcare PR, Highly competitive package: Highly Competitive package

Medical Writers: Competitive Salary and Benefits

Healthcare Advertising Senior Account Manager / AD / Senior AD: Salary TBC

SENIOR MEDICAL WRITER IN ONCOLOGY: Up to £60, 000.00 pension bonus

Account Manager, Healthcare Communications: £32, 000 - £40, 000 bonus benefits

Associate Director: £75, 000-90, 000

Digital Manager, London – Healthcare Brandcomms, Medcomms, PR: Excellent package

Account Manager / Senior Account Manager: 35, 000-40, 000

Senior Account Manager- Central Oxford and Abingdon: Negotiable

Account Manager, Healthcare Public Affairs: £32, 000 – £40, 000 benefits

SAM – Health Behaviour/ Patient Adherence Healthcare Agency: Salary TBC

Senior Account Director development role to Business Director, H...: Excellent package

Senior Systematic Review Analyst - Oxford: Negotiable

Account Director: £48, 000 - £60, 000

Freelance Account Manager / Senior Account Manager - Medical Edu...: £300 per day

Leadership opportunity, Pricing & Market Access, UK, Substan...: Substantial six figure package

Senior Medical Writer: Competitive Salary

Senior Medical Writer (Remote Working): Competitive Salary Offered

New Business Director - PR: Competitive Salary and benefits

Account Manager / Account Director: Competative

Account Manager – Creative Healthcare Advertising – Central Lond...: Salary TBC

Subscribe to our email news alerts

PMHub

Add my company

EY Life Sciences

Our global reach Against a backdrop of regulatory, digital, financial and global transformation, Life Sciences companies are finding integration and...

Latest intelligence

OUTiCO win Best in UK Pharmaceutical Outsourcing award: The Corporate LiveWire Healthcare and Life Sciences Awards celebrate global companies and individuals who have excelled over the past 12 months....
Artificial Intelligence in Healthcare: Artificial intelligence is already out-diagnosing experts, but would you put a computer in charge of your healthcare? The good, the bad; we take a look....
World Pancreatic Cancer Day 2018: Combating misconceptions in pancreatic cancer: Patients diagnosed with pancreatic cancer face a dismal prognosis, with the disease having the lowest survival rate of all major cancers. In spite of this, pancreatic cancer research is chronically...